AKT1 and pancreatic neoplasm: Another study also demonstrated the inhibition of Hsp90 by withaferin A in a pancreatic cancer cell line through the degradation of Akt, cyclin-dependent kinase 4 Cdk4, and a glucocorticoid receptor of Hsp90 client protein by an ATP-independent mechanism.